XRCC4 and glioblastoma: A prior study revealed that SBF2-AS1, an upregulated lncRNA in glioblastoma multiforme cells, promotes temozolomide (TMZ) resistance by functioning as a ceRNA for miR-151a-3p, disinhibiting its target XRCC4 and enhancing DNA repair [33].